FDA releases plan to boost biosimilars development

13-12-2018

FDA releases plan to boost biosimilars development

ll28 / iStockphoto.com

The US Food and Drug Administration (FDA) has announced new measures to advance the development of biosimilar medicines.


FDA, biosimilar, biologics, Scott Gottlieb, REMS, insulin

LSIPR